
0:00
8:42
Tam Maiuri, MaryAnn Emerick, and Allison Bartlett touch base on uniQure’s announcement that the FDA has accepted its application for AMT-130 and granted Priority Review, with a target action date of May 1, 2027. Join them for a brief conversation about this latest development for the Huntington’s disease community.
Don't forget to follow us on social media!
More episodes from "The HDSA Podcast"



Don't miss an episode of “The HDSA Podcast” and subscribe to it in the GetPodcast app.








